Dietary, circulating beta-carotene and risk of all-cause mortality: a meta-analysis from prospective studies

作者：Zhao, Long-Gang; Zhang, Qing-Li; Zheng, Jia-Li; Li, Hong-Lan; Zhang, Wei; Tang, Wei-Guo; Xiang, Yong-Bing^*

来源：Scientific Reports, 2016, 6(1): 26983.

DOI：10.1038/srep26983

• CARDIOVASCULAR-DISEASE MORTALITY
• CORONARY-HEART-DISEASE
• VITAMIN-A
• ANTIOXIDANT VITAMINS
• PREDICT MORTALITY
• SERUM CAROTENOIDS
• ALPHA-TOCOPHEROL
• OLDER PERSONS
• LUNG-CANCER
• FOLLOW-UP

Observational studies evaluating the relation between dietary or circulating level of beta-carotene and risk of total mortality yielded inconsistent results. We conducted a comprehensive search on publications of PubMed and EMBASE up to 31 March 2016. Random effect models were used to combine the results. Potential publication bias was assessed using Eggers and Beggs test. Seven studies that evaluated dietary beta-carotene intake in relation to overall mortality, indicated that a higher intake of beta-carotene was related to a significant lower risk of all-cause mortality (RR for highest vs. lowest group = 0.83, 95% CI: 0.78-0.88) with no evidence of heterogeneity between studies (I (2) = 1.0%, P = 0.416). A random-effect analysis comprising seven studies showed high beta-carotene level in serum or plasma was associated with a significant lower risk of all-cause mortality (RR for highest vs. lowest group = 0.69, 95% CI: 0.59-0.80) with low heterogeneity (I-2 = 37.1%, P = 0.145). No evidence of publication bias was detected by Beggs and Eggers regression tests. In conclusion, dietary or circulating beta-carotene was inversely associated with risk of all-cause mortality. More studies should be conducted to clarify the dose-response relationship between beta-carotene and all-cause mortality.

• 出版日期2016-5-31
• 单位上海交通大学; 上海市肿瘤研究所